Tags

Type your tag names separated by a space and hit enter

Refining CRISPR-based genome and epigenome editing off-targets.
Cell Biol Toxicol. 2019 08; 35(4):281-283.CB

Links

Publisher Full Text

Authors+Show Affiliations

Luo Y
BGI-Shenzhen, Shenzhen, 518083, China. luoyonglun@genomics.cn. Lars Bolund Institute of Regenerative Medicine, BGI-Qingdao, Qingdao, 266555, China. luoyonglun@genomics.cn. Department of Biomedicine, Aarhus University, 8000, Aarhus, Denmark. luoyonglun@genomics.cn. China National GeneBank, BGI-Shenzhen, Shenzhen, 518120, China. luoyonglun@genomics.cn.

MeSH

CRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsDNA MethylationEpigenomeGene EditingGenomeHumans

Pub Type(s)

Editorial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

31227932

Citation

Luo, Yonglun. "Refining CRISPR-based Genome and Epigenome Editing Off-targets." Cell Biology and Toxicology, vol. 35, no. 4, 2019, pp. 281-283.
Luo Y. Refining CRISPR-based genome and epigenome editing off-targets. Cell Biol Toxicol. 2019;35(4):281-283.
Luo, Y. (2019). Refining CRISPR-based genome and epigenome editing off-targets. Cell Biology and Toxicology, 35(4), 281-283. https://doi.org/10.1007/s10565-019-09482-8
Luo Y. Refining CRISPR-based Genome and Epigenome Editing Off-targets. Cell Biol Toxicol. 2019;35(4):281-283. PubMed PMID: 31227932.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Refining CRISPR-based genome and epigenome editing off-targets. A1 - Luo,Yonglun, Y1 - 2019/06/22/ PY - 2019/05/28/received PY - 2019/06/12/accepted PY - 2019/6/23/pubmed PY - 2020/7/21/medline PY - 2019/6/23/entrez SP - 281 EP - 283 JF - Cell biology and toxicology JO - Cell Biol. Toxicol. VL - 35 IS - 4 SN - 1573-6822 UR - https://www.unboundmedicine.com/medline/citation/31227932/Refining_CRISPR_based_genome_and_epigenome_editing_off_targets_ L2 - https://doi.org/10.1007/s10565-019-09482-8 DB - PRIME DP - Unbound Medicine ER -